Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q1

4078.TEDINET S100OUSM
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥21.4bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥80.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥19.6bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.8bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥2.1bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥2.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥8.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥2.6bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.8bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.6bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥127.2bnat 2022-06-30Cons.Assets
Total assets¥123.9bnat 2022-03-31Cons.Assets
Total assets¥123.6bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥43.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥41.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥84.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥82.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥80.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥12.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥10.8bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥109.42022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥97.222021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.2%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥435m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥435m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥558m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-06-30¥19.8bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-06-30¥19.5bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥360m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.3bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-06-30¥2.0bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥74m
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-06-30¥89m
—segment totalrevenue2022-04-01 → 2022-06-30¥21.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥21.4bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥435m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥449m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥449m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥521m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue external2021-04-01 → 2021-06-30¥17.7bn
jpcrp040300-q1r_E00780-000Chemicalreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥385m
jpcrp040300-q1r_E00780-000Chemicalreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥63m
jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segmentsegment profit2021-04-01 → 2021-06-30¥27m
—segment totalrevenue2021-04-01 → 2021-06-30¥20.0bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥19.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥449m
—segment totalsegment profit2021-04-01 → 2021-06-30¥2.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 363
ItemContextValueUnit
Extraordinary lossPrior1YTDDuration62000000JPY
Extraordinary lossCurrentYTDDuration5000000JPY
Income before income taxesPrior1YTDDuration2387000000JPY
Income before income taxesCurrentYTDDuration2573000000JPY
Income taxesPrior1YTDDuration672000000JPY
Income taxesCurrentYTDDuration734000000JPY
Profit lossPrior1YTDDuration1715000000JPY
Profit lossCurrentYTDDuration1838000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration78000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration69000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1636000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1769000000JPY
Profit lossPrior1YTDDuration1715000000JPY
Profit lossCurrentYTDDuration1838000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-526000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-271000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-16000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration39000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration178000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration326000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-5000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-0JPY
Other comprehensive incomePrior1YTDDuration-370000000JPY
Other comprehensive incomeCurrentYTDDuration95000000JPY
Comprehensive incomePrior1YTDDuration1344000000JPY
Comprehensive incomeCurrentYTDDuration1933000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1202000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1777000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration141000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration156000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember17695000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember1881000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember19577000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration19577000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember385000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember63000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember449000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-449000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember18080000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember1945000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember20026000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-449000000JPY
Net salesPrior1YTDDuration19577000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember2632000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember27000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember2660000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-521000000JPY
Operating incomePrior1YTDDuration2138000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass